市场调查报告书
商品编码
1417696
G 蛋白偶联受体市场报告:2030 年趋势、预测与竞争分析G Protein Coupled Receptor Market Report: Trends, Forecast and Competitive Analysis to 2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
G 蛋白偶联受体趋势与预测
预计到 2030 年,全球 G 蛋白偶联受体市场将达到约 87 亿美元,2024 年至 2030 年CAGR为6.7%。该市场的主要驱动因素是心血管疾病患病率上升、与研发工作相关的成本不断增加。创造创新的医药产品和治疗方法,以及越来越多地采用药物传输流程。全球G蛋白偶联受体市场的未来前景广阔,在癌症研究、中枢神经系统研究、代谢研究、心血管研究、呼吸系统研究和发炎研究市场都有机会。
G 蛋白偶联受体(按片段)
该研究包括按产品、检测类型、应用和区域对全球 G 蛋白偶联受体的预测。
G 蛋白偶联受体市场洞察
Lucintel 预测,在预测期内,细胞系仍将是最大的部分,因为有多种细胞係可用于测试,且细胞系的使用在用于识别 GPCR 靶点的细胞阻抗实验中至关重要。
由于癌症研究资金、GPCR 标靶药物的批准以及对该地区药物开发和发现计划的更加重视,北美在预测期内仍将是最大的地区。
Q1. 市场规模は:
A1。到 2030 年,全球 G 蛋白偶联受体市场预计将达到 87 亿美元。
Q2. 市场の成长予测は:
A2。预计2024年至2030年全球G蛋白偶联受体市场将以6.7%的CAGR成长。
Q3. 市场の成长に影响を与える主な促进要因は:
A3。该市场的主要驱动力是心血管疾病盛行率的上升、旨在创造创新药物和治疗方法的研发工作相关成本的增加以及药物输送过程的日益采用。
Q4. 市场の主要セグメントは:
A4。全球G蛋白偶联受体市场的未来前景广阔,在癌症研究、中枢神经系统研究、代谢研究、心血管研究、呼吸系统研究和发炎研究市场都有机会。
Q5. 市场の主要企业は:
A5。一些主要的 G 蛋白偶联受体公司如下。
Q6. 今后、最大となる市场セグメントは:
A6。 Lucintel 预测,在预测期内,细胞系仍将是最大的部分,因为有多种细胞係可用于测试,且细胞系的使用在用于识别 GPCR 靶点的细胞阻抗实验中至关重要。
Q7. 市场において、今后5年间に最大になると予想される地域は:
A7。由于癌症研究资金、GPCR 标靶药物的批准以及对该地区药物开发和发现计划的更加重视,北美在预测期内仍将是最大的地区。
Q8. レポートのカスタマイズは可能か:
A8。是的,Lucintel 提供 10% 的客製化服务,无需任何额外费用。
G Protein Coupled Receptor Trends and Forecast
The future of the global G protein coupled receptor market looks promising with opportunities in the cancer research, CNS research, metabolic research, cardiovascular research, respiratory research, and inflammation research markets. The global G protein coupled receptor market is expected to reach an estimated $8.7 billion by 2030 with a CAGR of 6.7% from 2024 to 2030. The major drivers for this market are rising prevalence of cardiovascular diseases, growing costs associated with research and development efforts aimed at creating innovative pharmaceutical products and treatment, along with the increasing adoption of drug delivery processes.
A more than 150-page report is developed to help in your business decisions.
G Protein Coupled Receptor by Segment
The study includes a forecast for the global G protein coupled receptor by product, assay type, application, and region.
List of G Protein Coupled Receptor Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies G protein coupled receptor companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the G protein coupled receptor companies profiled in this report include-
G Protein Coupled Receptor Market Insights
Lucintel forecasts that cell lines will remain the largest segment over the forecast period because a wide variety of cell lines are available for the tests, and the use of cell lines is crucial in cellular impedance experiments used to identify GPCR targets.
North America will remain the largest region over the forecast period because of the funds for cancer research, the approving of GPCR-targeted medications, and a stronger emphasis on the region's drug development and discovery initiatives.
Features of the Global G Protein Coupled Receptor Market
Market Size Estimates: G protein coupled receptor market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: G protein coupled receptor market size by product, assay type, application, and region in terms of value ($B).
Regional Analysis: G protein coupled receptor market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product, assay type, application, and regions for the G protein coupled receptor market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the G protein coupled receptor market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the G protein coupled receptor market size?
Answer: The global G protein coupled receptor market is expected to reach an estimated $8.7 billion by 2030.
Q2. What is the growth forecast for G protein coupled receptor market?
Answer: The global G protein coupled receptor market is expected to grow with a CAGR of 6.7% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the G protein coupled receptor market?
Answer: The major drivers for this market are rising prevalence of cardiovascular diseases, growing costs associated with research and development efforts aimed at creating innovative pharmaceutical products and treatment, along with the increasing adoption of drug delivery processes.
Q4. What are the major segments for G protein coupled receptor market?
Answer: The future of the global G protein coupled receptor market looks promising with opportunities in the cancer research, CNS research, metabolic research, cardiovascular research, respiratory research, and inflammation research markets.
Q5. Who are the key G protein coupled receptor market companies?
Answer: Some of the key G protein coupled receptor companies are as follows.
Q6. Which G protein coupled receptor market segment will be the largest in future?
Answer: Lucintel forecasts that cell lines will remain the largest segment over the forecast period because a wide variety of cell lines are available for the tests, and the use of cell lines is crucial in cellular impedance experiments used to identify GPCR targets.
Q7. In G protein coupled receptor market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period because of the funds for cancer research, the approving of GPCR-targeted medications, and a stronger emphasis on the region's drug development and discovery initiatives.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.